GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis
GNX-4728 是一种新型小分子药物，可抑制线粒体通透性转换，在肌萎缩侧索硬化症小鼠模型中具有治疗作用。
期刊:Frontiers in Cellular Neuroscience
影响因子:4
doi:10.3389/fncel.2014.00433
Martin, Lee J; Fancelli, Daniele; Wong, Margaret; Niedzwiecki, Mark; Ballarini, Marco; Plyte, Simon; Chang, Qing
